Sanofi drops deal with Maze for Pompe disease drug after FTC threatens lawsuitnews2023-12-11T21:42:06+00:00December 11th, 2023|Endpoints News|
Ferring Pharmaceuticals lays off 134 employees between NJ and MN locationsnews2023-12-11T20:18:04+00:00December 11th, 2023|Endpoints News|
Bipartisan House bill seeks to boost pediatric drug development via new FDA penalties for noncompliancenews2023-12-11T20:12:50+00:00December 11th, 2023|Endpoints News|
J&J accused of defrauding US Patent Office in anti-competition lawsuitnews2023-12-11T19:14:23+00:00December 11th, 2023|Endpoints News|
After two historic approvals, Editas unveils promising early results for its sickle cell therapy: #ASH23news2023-12-11T17:01:38+00:00December 11th, 2023|Endpoints News|
Kamau Therapeutics presents follow-up data on nula-cel after side effects doomed Graphite Bionews2023-12-11T17:00:02+00:00December 11th, 2023|Endpoints News|
Catalent details revenue downturn, staff cuts as it looks forward to a brighter 2024news2023-12-11T16:02:50+00:00December 11th, 2023|Endpoints News|
Affimed narrows PhI/IIa focus; Bristol Myers pays Agenus $25M; Merck, Moderna start another PhIII cancer vaccinenews2023-12-11T15:17:48+00:00December 11th, 2023|Endpoints News|
Q&A: Aviv Regev talks three years at Genentech, future of AI in biotechnews2023-12-11T14:42:18+00:00December 11th, 2023|Endpoints News|
ICER unveils latest report on ‘unsupported’ drug price increasesnews2023-12-11T13:19:56+00:00December 11th, 2023|Endpoints News|
